Communiqués STADA Arzneimittel

Actions

SAZ

DE0007251803

Produits pharmaceutiques

Temps Différé Xetra Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^EUR	-.--%		-1,95%	-8,87%

10/11/23	Alvotech et Stada obtiennent le soutien du comité de l'UE pour le biosimilaire de Stelara	MT
25/07/23	Xbrane Biopharma et Stada envisagent des options pour le ranibizumab	FW

Communiqués

26/05/23	STADA AND XBRANE LAUNCH XIMLUCI AS RANIBIZUMAB BIOSIMILAR IN GERMANY	AQ
08/02/23	European Biosimilar Regulatory Updates	AQ
15/11/22	STADA And Xbrane Announce Approval Of Ranibizumab Biosimilar In Europe	AQ
21/12/20	STADA Arzneimittel : Every 2nd European does not know their vaccination status	PU
21/12/20	Digital Doctors: Europeans open to apps on prescription	PU
07/02/20	STADA Arzneimittel : to acquire established OTC and food supplement portfolio in the Philippines	PU
29/01/20	STADA Arzneimittel : Wolfgang Ollig to become new CFO of the STADA Group	PU
02/12/19	STADA Arzneimittel : to Become a Major Pharma Player in Ukraine by Acquiring Biopharma’s Pharmaceutical Prescription and Consumer Health Business	PU
06/11/19	STADA Arzneimittel : Alvotech and STADA agree on strategic biosimilar partnership	PU
05/11/19	STADA Arzneimittel : invests $660 Million USD in Takeda’s OTC portfolio in Russia/CIS	PU
04/11/19	STADA Arzneimittel : to acquire Walmark – a leading Consumer Healthcare company in Central Europe	PU
21/06/19	STADA Arzneimittel : Announcement of the Results of the Tender Offer	EQ
23/05/19	STADA Arzneimittel : Upcoming Expiration of Tender Offer and Intention to Delist Notes	EQ
21/05/19	STADA Arzneimittel : Announcement of the Results of the Tender Offer	EQ
23/04/19	STADA Arzneimittel : Announcement of the Results of the Tender Offer	EQ
21/03/19	STADA Arzneimittel AG: Announcement of the Results of the Tender Offer	EQ
21/02/19	STADA Arzneimittel : Announcement of the Results of the Tender Offer	EQ
22/01/19	STADA Arzneimittel : Announcement of the Results of the Tender Offer	EQ
08/01/19	STADA Arzneimittel : offer to purchase for cash any and all of its outstanding 1.750% Notes due 2022	EQ
20/12/18	STADA Arzneimittel : EUR 300,000,000 1.75% Senior Notes due 2022	EQ
28/11/18	STADA Arzneimittel AG: STADA: Completion of the compliance investigation	EQ
13/11/18	STADA's EUR300,000,000 1.75% Senior Notes due 2022: announcement of an instruction to grant in rem securities	EQ
01/10/18	DGAP-WpÜG: Tender Offer;	EQ
18/09/18	STADA Arzneimittel : Voting results of the bondholders’ meeting concerning the STADA-Bond 2015/2022	PU
18/09/18	STADA Arzneimittel AG: Voting results of the bondholders' meeting concerning the STADA-Bond 2015/2022	EQ